CD14 and coronary artery disorder: The consistent result of these studies was that the count of CD16 positive subsets was higher in patients with CAD and MI as compared with healthy controls.[34, 35] Rogacev et al. [9] found that the count of CD14++CD16+ Mon2 subsets was an independent predictor of adverse cardiovascular events.